Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

The Distribution Rate shown is as of 4 p.m. ET on October 23, 2025. The Distribution Rate is the annual rate an investor would receive if the most recently declared distribution, which includes option ...

Bitwise CIO Matt Hougan claims that Gold's 57% run in 2025 is paving the way for Bitcoin. Hougan highlights that central banks and institutions have been major investors in Gold compared to Bitcoin.

Smriti Mandhana and Pratika Rawal during their record 212-run stand in India Women’s win against New Zealandon Thursday. PTI The Indian women’s team’s batting didn’t quite fire on a regular basis in ...

The Chicago Bears had their best rushing outing in Sunday's win over the New Orleans Saints, where both D'Andre Swift and rookie Kyle Monangai had impressive showings. The Bears totaled 222 rushing ...

Bitcoin price roared past $113,000 today, climbing from $108,000 earlier in the session, as traditional safe-haven assets took a hit. Spot gold extended its losses to $4,085.39 per ounce, down more ...

Some large bitcoin holders are moving coins into spot exchange-traded funds through in-kind creations, converting off-platform BTC into brokerage-account assets they can borrow against or include in ...

GameSpot may get a commission from retail offers. The last big content drop for Helldivers 2 added new toys to play with and sandboxes to wreak havoc in, but with persistent player grievances about ...

The wind-down of defunct crypto lender Celsius coughed up almost $300 million from Tether, according to a Tuesday statement from an entity set up by GXD Labs and VanEck, the Blockchain Recovery ...

Spot Bitcoin and Ether exchange-traded funds (ETFs) in the United States saw combined outflows of more than $755 million on Monday following record crypto liquidations over the weekend. Bitcoin (BTC) ...

Novartis has filed suit against AstraZeneca’s rare disease unit, claiming that certain marketing materials for Alexion’s Ultomiris create an inaccurate impression of Novartis’ rival drug Fabhalta.

The U.S. SEC has approved the Form 8-A (12B) filed by asset manager 21Shares to custody the Solana Spot ETF. This long-awaited approval has reignited bullish sentiment, with traders eyeing a potential ...